SCHEMBL9711155

SCHEMBL9711155

Cc1cccc(S(=O)(=O)C[N+](=O)[O-])c1Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
TDP1 Q9NUW8 3/20 0.39
TSHR P16473 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
HSD17B10 Q99714 1/20 0.34
CRHBP P24387 1/20 0.33
CRHR2 Q13324 1/20 0.33
PDE2A O00408 1/20 0.33
PDE5A O76074 1/20 0.33
CYP3A4 P08684 1/20 0.33
ALOX15 P16050 1/20 0.33
NFKB1 P19838 1/20 0.33
APEX1 P27695 1/20 0.33
PDE4A P27815 1/20 0.33
BLM P54132 1/20 0.33
PDE1B Q01064 1/20 0.33
PMP22 Q01453 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4D Q08499 1/20 0.33
PDE7A Q13946 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9740376 0.83 TSHR (0.42) ALDH1A1TDP1TSHRMEN1KMT2A
SCHEMBL9652718 0.83 ALDH1A1 (0.43) ALDH1A1TDP1TSHRSMN1; SMN2HSD17B10
SCHEMBL9711152 0.81 HSD11B1 (0.41) ALDH1A1TDP1KMT2AL3MBTL1GAA
SCHEMBL5953621 0.78 TDP1 (0.45) ALDH1A1TDP1TSHRSMN1; SMN2HSD17B10
SCHEMBL9740686 0.76 HSD11B1 (0.41) ALDH1A1TSHRHSD17B10MEN1KMT2A
SCHEMBL1833873 0.75 ALDH1A1 (0.37) ALDH1A1TDP1TSHRHSD17B10KMT2A
SCHEMBL29673477 0.75 ALDH1A1 (0.37) ALDH1A1TDP1TSHRHSD17B10KMT2A
SCHEMBL7106886 0.73 GAA (0.38) ALDH1A1TSHRKMT2AAKR1B1L3MBTL1
SCHEMBL9711168 0.72 SOD1 (0.49) TSHRKMT2ACA1CA2CA9
SCHEMBL9349866 0.72 ALDH1A1 (0.31) ALDH1A1TDP1MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5153227-A Treatment of diabetes and galactosemia complications IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1992-10-06 US claimed
EP-0304190-B1 (ARYLSULPHONYL)NITROMETHANES, PROCESS FOR THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1992-07-08 EP claimed
EP-0304190-A1 (Arylsulphonyl)nitromethanes, process for their preparation and use in pharmaceutical compositions IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1989-02-22 EP claimed
US-5153227-A Treatment of diabetes and galactosemia complications IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1992-10-06 US disclosed
EP-0304190-B1 (ARYLSULPHONYL)NITROMETHANES, PROCESS FOR THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1992-07-08 EP disclosed
EP-0304190-A1 (Arylsulphonyl)nitromethanes, process for their preparation and use in pharmaceutical compositions IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1989-02-22 EP disclosed